Insights

Niche Market Focus As a specialized vitreoretinal healthcare provider with a small team, Taylor Vitreoretinal Center likely serves a localized patient base, presenting opportunities to offer tailored medical devices, surgical equipment, and ophthalmic pharmaceuticals suited for retinal care.

Growth Potential The company's modest revenue indicates room for expansion, suggesting opportunities to introduce innovative retinal treatment solutions or enhance existing product lines to support their clinical services and attract more patients.

Competitive Landscape Operating in a market with large ophthalmology groups generating significantly higher revenues, Taylor Vitreoretinal Center could benefit from partnerships or supply agreements with device manufacturers aiming to penetrate smaller or specialized clinics.

Technology Adoption With limited information on their tech stack, engaging the company in technologically advanced diagnostic tools, minimally invasive surgical instruments, or digital health solutions could enhance their service offerings and operational efficiency.

Regional Expansion Located in Raleigh, North Carolina, the company presents a strategic opportunity for regional outreach initiatives, expanding patient access through new clinics or telemedicine collaborations supported by innovative pharmaceutical or equipment vendors.

Taylor Vitreoretinal Center Tech Stack

Media & News

Taylor Vitreoretinal Center's Email Address Formats

Taylor Vitreoretinal Center uses at least 2 format(s):
Taylor Vitreoretinal Center Email FormatsExamplePercentage
FLast@taylorretinacenter.comJDoe@taylorretinacenter.com
57%
First.Last@taylorretinacenter.comJohn.Doe@taylorretinacenter.com
43%

Frequently Asked Questions

Where is Taylor Vitreoretinal Center's headquarters located?

Minus sign iconPlus sign icon
Taylor Vitreoretinal Center's main headquarters is located at 1212 Cedarhurst Drive Raleigh, North Carolina 27609 United States. The company has employees across 1 continents, including North America.

What is Taylor Vitreoretinal Center's official website and social media links?

Minus sign iconPlus sign icon
Taylor Vitreoretinal Center's official website is taylorretinal.com and has social profiles on LinkedIn.

What is Taylor Vitreoretinal Center's NAICS code?

Minus sign iconPlus sign icon
Taylor Vitreoretinal Center's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Taylor Vitreoretinal Center have currently?

Minus sign iconPlus sign icon
As of January 2026, Taylor Vitreoretinal Center has approximately 2 employees across 1 continents, including North America. Key team members include Chief Executive: N. G.Billing Manager: M. T.Principal: J. T.. Explore Taylor Vitreoretinal Center's employee directory with LeadIQ.

What industry does Taylor Vitreoretinal Center belong to?

Minus sign iconPlus sign icon
Taylor Vitreoretinal Center operates in the Pharmaceutical Manufacturing industry.

What is Taylor Vitreoretinal Center's email format?

Minus sign iconPlus sign icon
Taylor Vitreoretinal Center's email format typically follows the pattern of FLast@taylorretinacenter.com. Find more Taylor Vitreoretinal Center email formats with LeadIQ.

Taylor Vitreoretinal Center

Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees

Taylor Vitreoretinal Center is a Pharmaceuticals company located in 1212 Cedarhurst Dr, Raleigh, North Carolina, United States.

Section iconCompany Overview

Headquarters
1212 Cedarhurst Drive Raleigh, North Carolina 27609 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Taylor Vitreoretinal Center's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Taylor Vitreoretinal Center's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.